Using a stent graft to keep open failing arteriovenous dialysis grafts results in better patency and fewer reinterventions than angioplasty alone. Twelve-month results of the RENOVA trial were ...

Improvements in patency potentially enable uninterrupted dialysis and reduced use of central venous catheters. Drug-coated balloon angioplasty maintains patency better than standard balloon ...

Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — In patients with dysfunctional hemodialysis arteriovenous fistulae, adding a drug-coated balloon to ...

Standard percutaneous transluminal angioplasty is the current recommended treatment for dysfunctional hemodialysis fistulas, yet long-term outcomes of this treatment are poor. Drug-coated balloons ...

Because stent implantation for disease of the superficial femoral artery has been associated with high rates of late clinical failure, percutaneous transluminal angioplasty is preferred for ...

C.R. Bard scored FDA premarket approval for its Lutonix drug-coated balloon to treat a new indication: stenosis in the arteriovenous (AV) fistulae of patients with end-stage renal disease. The Lutonix ...

Today, the U.S. Food and Drug Administration permitted marketing of two catheter-based devices designed to create a connection to veins and arteries in patients with chronic kidney disease who need ...

Coronary artery disease, a major global health concern, is effectively managed through angioplasty or bypass surgery. Angioplasty offers a minimally invasive option for single blockages with rapid ...

Both the angiogram and angioplasty are useful tools when diagnosing and treating blockages and other heart issues. Both procedures are performed on an outpatient basis and are minimally invasive. If ...

Balloon angioplasty is a minimally invasive procedure to treat blocked or narrowed arteries. It involves inserting a tiny balloon into a blood vessel and inflating it to treat blockages and improve ...

Adding balloon angioplasty to aggressive medical management significantly lowers the risk for stroke or death in patients with symptomatic intracranial atherosclerotic stenosis (sICAS), results of a ...